Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)

Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01788592

Enrollment

50000

Registered

2013-02-11

Start date

2003-01-31

Completion date

2030-10-31

Last updated

2026-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

coronary artery disease, drug eluting stent

Brief summary

The objective of this study is to evaluate effectiveness and safety of drug-eluting stent implantation in the real world daily practice.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* coronary disease amenable to percutaneous coronary intervention (PCI) * no clinical and lesion limitations

Exclusion criteria

* patients with a mixture of several drug eluting stents * terminal illness with life expectancy less than 1 year * patients with cardiogenic shock

Design outcomes

Primary

Measure	Time frame	Description
Major Adverse Cardiac Event	1year	Death from any causes, myocardial infarction or any repeat revascularization

Secondary

Measure	Time frame
Myocardial Infarction	1year
The composite of Death or myocardial infarction	1year
Any repeat revascularization	1year
all cause Death	1year
Target lesion revascularization	1year
New lesion revascularization	1year
Stent thrombosis by Academic Research Consortium criteria	1year
Target vessel revascularization	1year

Countries

South Korea

Outcome results